This session sets the context for the off-label promotion of medical products starting with early history and moving to the most recent history of FDA’s decision on guidance documents.

Why should you Attend:
This session will discuss comments from industry, health care providers, health care insurers and other concerned parties. The latest legal considerations, decisions and conclusions will be discussed as well as future expectations for off-label promotion of medical products.

Who Will Benefit:
Quality Managers
Quality Engineers
Regulatory Affairs
Regulatory Attorneys
Doctors
Health Insurance

Speaker Profile:
Angela Bazigos is the CEO of Touchstone Technologies Inc. She has degrees in Microbiology and Computing and 40 years of experience in the Life Sciences, Healthcare & Public Health Services. Experience combines Quality Assurance, Regulatory Compliance, Business Administration, Information Technology, Project Management, Clinical Lab Science, Microbiology, Food Safety & Turnarounds. Past employers / clients include Royal Berkshire Hospital, Roche, Novartis, Genentech, PriceWaterhouseCoopers & Stanford Hospital.

Event Fee: One Dial-in One Attendee Price: US$290.00

Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: [email protected]

http://www.compliance4all.com/control/w_product/~product_id=501686LIVE?channel=ndnr_Jun_2018_SEO